IAG - Image Analysis Group

Image Analysis logo

IAG is a strategic partner to bio-pharmacutical companies. We bring extensive therapeutic knowledge and regulatory expertise in strategic use of clinical imaging to enhance understanding of the mode of action, to increase the efficiency of clinical decisions and to accelerate drug development.

IAG’s operations team leverage our global footprint and the next-generation cloud based proprietry platform Dynamika to de-risk trial execution and to ensure data quality and integrity. Our venture arm pioneer unique targeted investment and risk-sharing models to enable our clients to reach the next value inflection point faster. We fuse decades of theraputic insight and agile culture to meet today's speed and high standard of therapeutic innovation.

Contact IAG - Image Analysis Group via their website

News archive

19/03/2019   Medicenna and IAG, Image Analysis Group, announce alliance to develop MDNA55...more
13/02/2019   IAG Expands Leadership Team...more
23/01/2019   IAG Strengthens its Clinical Trial Operations Team...more

28/09/2018   IAG Appoints Dr. Christophe Berthoux as Chairman To The Board...more
07/02/2018   IAG Opens New Office In Philadelphia...more
27/01/2018   IAG Joins Forces With ImageBiopsy Lab For Osteoarthritis Clinical Research...more

23/10/2017   IAG Partners with Leading Academics to Provide AI-powered MRI Analysis...more
25/05/2017   Image Analysis Group Announces FDA Clearance for Dynamika Platform...more
19/05/2017   Image Analysis reports on Drug Development in Osteoarthritis...more
21/04/2017   Image Analysis Group share $585,000 Innovate UK grant for MRI brain tumour biomarkers...more
21/03/2017   Image Analysis joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code